Using GBM cell lines isogenic for EGFRwt and EGFRvIII, we unraveled novel findings related to the impact of EGFR alterations on the response to auranofin or the combination of auranofin with L-BSO as pro-oxidant strategies (Figure 6). Here, EGFR is linked to glioblastoma.